Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Zhuang, Huiyu ^a   Tan, Mingzi ^a   Liu, Juanjuan ^a   Hu, Zhenhua ^a   Liu, Dawo ^a   Gao, Jian ^a   Zhu, Liancheng ^a   Lin, Bei ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Annexin II; Human epididymis protein 4; Invasion; Metastasis; Ovarian cancer

Indexed keywords

HUMAN EPIDIDYMIS PROTEIN 4; LIPOCORTIN 2; MITOGEN ACTIVATED PROTEIN KINASE; FOCAL ADHESION KINASE; LAMININ; LAMININ BETA2; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MKNK2 PROTEIN, HUMAN; PROTEIN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; WFDC2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ANXA2 GENE; ARTICLE; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM; FEMALE; GENE; HE4 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; OVARIAN CANCER CELL LINE; OVARY METASTASIS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VERY ELDERLY; EPITHELIUM CELL; GENETICS; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ANIMALIA;

ANNEXIN A2; CELL LINE, TUMOR; DOWN-REGULATION; EPITHELIAL CELLS; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LAMININ; LYMPHATIC METASTASIS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; SIGNAL TRANSDUCTION;

EID: 84926627542     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-243     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 1, 58:71-96. 10.3322/CA.2007.0010
2. BW S: KP: WHO World Cancer Report. Lyon (France): IARC Press; 2003.
3. Schummer M, Ng WV, Bumgarner RE, Nelson PS, Schummer B, Bednarski DW, Hassell L, Baldwin RL, Karlan BY, Hood L: Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. Gene 1, 238:375-385. 10.1016/S0378-1119(99)00342-X
4. Hellstrom I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, Drescher C, Urban N, Hellstrom KE: The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res 2003, 63:3695-3700.
5. Wang K, Gan L, Jeffery E, Gayle M, Gown AM, Skelly M, Nelson PS, Ng WV, Schummer M, Hood L, Mulligan J: Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 1, 229:101-108. 10.1016/S0378-1119(99)00035-9
6. Yu S, Yang HJ, Xie SQ, Bao YX: Diagnostic value of HE4 for ovarian cancer: a meta-analysis. Clin Chem Lab Med 2012, 50:1439-1446.
7. Drapkin R, von Horsten HH, Lin Y, Mok SC, Crum CP, Welch WR, Hecht JL: Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res 1, 65:2162-2169. 10.1158/0008-5472.CAN-04-3924
8. Lu R, Sun X, Xiao R, Zhou L, Gao X, Guo L: Human epididymis protein 4 (HE4) plays a key role in ovarian cancer cell adhesion and motility. Biochem Biophys Res Commun 1, 419:274-280. 10.1016/j.bbrc.2012.02.008
9. Zhu YF, Gao GL, Tang SB, Zhang ZD, Huang QS: Effect of WFDC 2 silencing on the proliferation, motility and invasion of human serous ovarian cancer cells in vitro. Asian Pac J Trop Med 1, 6:265-272. 10.1016/S1995-7645(13)60055-3
10. Chasserot-Golaz S, Vitale N, Umbrecht-Jenck E, Knight D, Gerke V, Bader MF: Annexin 2 promotes the formation of lipid microdomains required for calcium-regulated exocytosis of dense-core vesicles. Mol Biol Cell 1, 16:1108-1119. 10.1091/mbc.E04-07-0627
11. Semov A, Moreno MJ, Onichtchenko A, Abulrob A, Ball M, Ekiel I, Pietrzynski G, Stanimirovic D, Alakhov V: Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. J Biol Chem 1, 280:20833-20841. 10.1074/jbc.M412653200
12. Tanaka T, Akatsuka S, Ozeki M, Shirase T, Hiai H, Toyokuni S: Redox regulation of annexin 2 and its implications for oxidative stress-induced renal carcinogenesis and metastasis. Oncogene 1, 23:3980-3989. 10.1038/sj.onc.1207555
13. Bjornland K, Winberg JO, Odegaard OT, Hovig E, Loennechen T, Aasen AO, Fodstad O, Maelandsmo GM: S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res 1999, 59:4702-4708.
14. Mathisen B, Lindstad RI, Hansen J, El-Gewely SA, Maelandsmo GM, Hovig E, Fodstad O, Loennechen T, Winberg JO: S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells. Clin Exp Metastasis 2003, 20:701-711.
15. Ortiz-Zapater E, Peiro S, Roda O, Corominas JM, Aguilar S, Ampurdanes C, Real FX, Navarro P: Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2. Am J Pathol 1, 170:1573-1584. 10.2353/ajpath.2007.060850
16. Delys L, Detours V, Franc B, Thomas G, Bogdanova T, Tronko M, Libert F, Dumont JE, Maenhaut C: Gene expression and the biological phenotype of papillary thyroid carcinomas. Oncogene 1, 26:7894-7903. 10.1038/sj.onc.1210588
17. Zhang Y, Zhou ZH, Bugge TH, Wahl LM: Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin. J Immunol 1, 179:3297-3304. 10.4049/jimmunol.179.5.3297
18. Sabbatini PJ, Ragupathi G, Hood CAC, Juretzka M, Iasonos A, Hensley ML, Spassova MK, Ouerfelli O, Spriggs DR, Tew WP, Konner J, Clausen H, Abu RN, Dansihefsky SJ, Livingston PO: Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer. Clin Cancer Res 2007, 14:2631-2638.
19. LeBleu VS, Teng Y, O'Connell JT, Charytan D, Muller GA, Muller CA, Sugimoto H, Kalluri R: Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat Med 1, 19:227-231. 10.1038/nm.2989
20. Zhuang H, Gao J, Hu Z, Liu J, Liu D, Lin B: Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma. PLoS One 1, 8:e68994. 10.1371/journal.pone.0068994
21. Zhuang H, Hu Z, Tan M, Zhu L, Liu J, Liu D, Yan L, Lin B: Overexpression of Lewis y antigen promotes human epididymis protein 4-mediated invasion and metastasis of ovarian cancer cells. Biochimie 2014, 105:91-98.
22. Gallagher SJ, Luciani F, Berlin I, Rambow F, Gros G, Champeval D, Delmas V, Larue L: General strategy to analyse melanoma in mice. Pigment Cell Melanoma Res 1, 24:987-988. 10.1111/j.1755-148X.2011.00907.x